Unlicensed applications of licensed psychotropic drugs in an intellectual disability clinical service: Retrospective case-note study

Journal of Intellectual Disabilities

Volumn 14, Issue 3, 2010, Pages 237-243

  Ghosh, Soumya ^a   Arulrajan, Arum E ^b   Baldwin, David ^c  

^a HERTFORDSHIRE PARTNERSHIP UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b SOUTHERN HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

case note survey; community service; intellectual disability; psychotropic medication; unlicensed prescribing

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; HALOPERIDOL; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; THIORIDAZINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL;

ADULT; AGGRESSION; ARTICLE; BEHAVIOR DISORDER; CASE STUDY; FEMALE; HUMAN; INTELLECTUAL IMPAIRMENT; LICENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; PHYSICAL DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ENGLAND; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MENTAL RETARDATION; MIDDLE AGED; OFF-LABEL USE; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 78651245504     PISSN: 17446295     EISSN: 17446309     Source Type: Journal    
DOI: 10.1177/1744629510381943     Document Type: Article

References (10)

1. Baldwin, D.S. & Kosky, N. (2007) 'Use of Licensed Medicines for Unlicensed Applications in Psychiatric Practice', Advances in Psychiatric Treatment, 13: 414-22.
2. Bramble, D. (2007) 'Psychotropic Drug Prescribing in Child and Adolescent Learning Disability Psychiatry', Journal of Psychopharmacology, 21: 486-91.
3. Deb, S. & Unwin, G.L. (2007) 'Psychotropic Medication for Behaviour Problems in People with Intellectual Disability: A Review', Current Opinion in Psychiatry, 5: 461-6.
4. Deb, S., Sohanpal, S.K., Soni, R., Lenôtre, L. & Unwin, G. (2007) 'The Effectiveness of Antipsychotic Medication in the Management of Behavioural Problems in Adults with Intellectual Disabilities', Journal of Intellectual Disability Research, 51: 766-77.
5. Doey, T., Handelman, K., Seabrook, J.A. & Steele, M. (2007) 'Survey of Atypical Antipsychotic Prescribing by Canadian Child Psychiatrists and Developmental Paediatricians for Patients Aged under 18 years', Canadian Journal of Psychiatry, 52: 363-8.
6. Gagiano, C., Read, S., Thorpe, L., Eerdekens, H. & Van Hove, I. (2005) 'Short- and Long-Term Efficacy and Safety of Risperidone in Adults with Disruptive Behavior Disorders', Psychopharmacology, 179: 629-36.
7. Haw, C. & Stubbs, J. (2005) 'A Survey of Off-Label Prescribing for Inpatients with Mild Intellectual Disability and Mental Illness', Journal of Intellectual Disability Research, 49: 858-84.
8. Royal College of Psychiatrists (2007) Use of Licensed Medicines for Unlicensed Applications in Psychiatric Practice. Report CR142.
9. Sawhney, I., Morgan, J. & Chandra, P. (2006) 'Survey of Off-Label Prescribing in Learning Disability', Primary Care and Community Psychiatry, 11: 153-6.
10. Tyrer, P., Oliver-Africano, P.C., Ahmed, Z., Bouras, N., Cooray, S., Deb, S. & Murphy, D. (2008) 'Risperidone, Haloperidol and Placebo in the Treatment of Aggressive Challenging Behaviour in Patients with Intellectual Disability: A Randomised Controlled Trial', Lancet 371: 57-63.